TransMedics (TMDX) Operating Expenses (2018 - 2026)

TransMedics' Operating Expenses history runs 9 years deep, the most recent figure standing at $87.9 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 44.55% year-over-year to $87.9 million; the TTM figure through Mar 2026 stood at $281.3 million (up 18.28% YoY), while the FY2025 annual figure was $254.2 million, up 13.2% from the prior year.
• Operating Expenses was $87.9 million for Q1 2026 at TransMedics, up from $72.1 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $87.9 million in Q1 2026 to a low of $21.5 million in Q1 2022.
• Historically, Operating Expenses has averaged $49.8 million across 5 years, with a median of $56.8 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses jumped 191.63% in 2023, then retreated 17.5% in 2024.
• A 5-year view of Operating Expenses shows it stood at $27.5 million in 2022, then soared by 64.91% to $45.3 million in 2023, then jumped by 39.82% to $63.4 million in 2024, then grew by 13.84% to $72.1 million in 2025, then grew by 21.79% to $87.9 million in 2026.
• The last three Operating Expenses figures came in at $87.9 million (Q1 2026), $72.1 million (Q4 2025), and $61.3 million (Q3 2025), per Business Quant data.